247 related articles for article (PubMed ID: 30279047)
41. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.
Hsin CH; Tseng HC; Lin HP; Chen TH
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):471-7. PubMed ID: 25634060
[TBL] [Abstract][Full Text] [Related]
42. Post-radiation sinusitis is associated with recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Huang CJ; Huang MY; Shih MP; Cheng KY; Lee KW; Lu TY; Yuan SS; Fang PT
Radiat Oncol; 2019 Apr; 14(1):61. PubMed ID: 30971260
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
44. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
45. Concordance of informant and self-reported ratings on the Frontal Systems Behavior Scale in adult survivors of pediatric brain tumor.
Haller OC; Tighe EL; King TZ
Clin Neuropsychol; 2024 Jan; 38(1):135-149. PubMed ID: 36987932
[TBL] [Abstract][Full Text] [Related]
46. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
47. [Comparison of temporomandibular joint injuries after three-dimensional conformal and intensity-modulated radiotherapies for nasopharyngeal carcinoma].
Chen D; Yu Y; Qi B; Liu J; Li M; Liang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):991-4. PubMed ID: 22820584
[TBL] [Abstract][Full Text] [Related]
48. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
Hua YJ; Han F; Lu LX; Mai HQ; Guo X; Hong MH; Lu TX; Zhao C
Eur J Cancer; 2012 Dec; 48(18):3422-8. PubMed ID: 22835782
[TBL] [Abstract][Full Text] [Related]
49. Comparison of Significant Carotid Stenosis for Nasopharyngeal Carcinoma between Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy.
Liao W; Zhou H; Fan S; Zheng Y; Zhang B; Zhao Z; Xiao S; Bai S; Liu J
Sci Rep; 2018 Sep; 8(1):13899. PubMed ID: 30224668
[TBL] [Abstract][Full Text] [Related]
50. Progression of cognitive dysfunction in NPC survivors with radiation-induced brain necrosis: A prospective cohort.
Zhu Y; Cheng J; Li Y; Pan D; Li H; Xu Y; Du Z; Lei M; Xiao S; Shen Q; Shi Z; Tang Y
Radiother Oncol; 2024 Jan; 190():110033. PubMed ID: 38030079
[TBL] [Abstract][Full Text] [Related]
51. Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors.
Kiang A; Weinberg VK; Cheung KH; Shugard E; Chen J; Quivey JM; Yom SS
Radiat Oncol; 2016 Sep; 11(1):127. PubMed ID: 27671196
[TBL] [Abstract][Full Text] [Related]
52. [The effect on life quality of nasopharyngeal cancer patients through xerostomia decrease after intensity-modulated radiotherapy].
Xie CY; Su HF; Li WF; Zhang XB; Zhang P; Wen HL; Wu SX
Zhonghua Yi Xue Za Zhi; 2010 May; 90(19):1313-6. PubMed ID: 20646578
[TBL] [Abstract][Full Text] [Related]
53. Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients?
Pow EH; Kwong DL; Sham JS; Lee VH; Ng SC
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e213-21. PubMed ID: 22386514
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
55. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
[TBL] [Abstract][Full Text] [Related]
56. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
[TBL] [Abstract][Full Text] [Related]
57. High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.
Sun PY; Chen YH; Feng XB; Yang CX; Wu F; Wang RS
Med Sci Monit; 2018 Dec; 24():8849-8859. PubMed ID: 30524119
[TBL] [Abstract][Full Text] [Related]
58. Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up.
Chen YY; Zhao C; Wang J; Ma HL; Lai SZ; Liu Y; Han F; Lu LX; Bao Y; Chen M
Cancer; 2011 Jul; 117(13):2910-6. PubMed ID: 21264821
[TBL] [Abstract][Full Text] [Related]
59. Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities.
Cao CN; Luo JW; Gao L; Yi JL; Huang XD; Wang K; Zhang SP; Qu Y; Li SY; Xiao JP; Zhang Z; Xu GZ
Oral Oncol; 2015 Feb; 51(2):190-4. PubMed ID: 25434585
[TBL] [Abstract][Full Text] [Related]
60. Long-term psychological outcomes following stroke: the OX-CHRONIC study.
Kusec A; Milosevich E; Williams OA; Chiu EG; Watson P; Carrick C; Drozdowska BA; Dillon A; Jennings T; Anderson B; Dawes H; Thomas S; Kuppuswamy A; Pendlebury ST; Quinn TJ; Demeyere N
BMC Neurol; 2023 Nov; 23(1):426. PubMed ID: 38036966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
